Correlation Engine 2.0
Clear Search sequence regions


  • acid (1)
  • antitumor (1)
  • bone (1)
  • bone neoplasms (1)
  • cancer (1)
  • cells kill (1)
  • homeostasis (1)
  • humans (1)
  • il 12 (7)
  • interleukin (1)
  • macrophages (1)
  • osteosarcoma (2)
  • patients (1)
  • t cells (1)
  • Sizes of these terms reflect their relevance to your search.

    Interleukin(IL)-12 is a protein that activates T cells and macrophages to kill tumor cells. However, despite this cytokine showing strong antitumor activity in preclinical settings, translation to patients has been slowed by toxic side effects, poor distribution to peripheral tissues, and improper dosing regimens. Osteosarcoma (OS) is an aggressive primary tumor of bone that has shown particular responsiveness to recombinant (r)IL-12 in preclinical models. Poly(lactic-co-glycolic) acid (PLGA) nanospheres, an FDA-approved drug delivery vector, may be a viable delivery vector for transporting biologically active IL-12 to tissues without disturbing normal homeostasis. In this chapter, we explore the potential for using IL-12-loaded nanospheres (IL-12-NS, <1 μm in diameter) to treat cancer, describe the synthesis process, and examine a typical protein release profile while providing insight and future directions of nanoscale tumor immunotherapeutics.

    Citation

    Justin E Markel, Ryan A Lacinski, Brock A Lindsey. Nanocapsule Delivery of IL-12. Advances in experimental medicine and biology. 2020;1257:155-168

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32483738

    View Full Text